Keyphrases
Basal Ganglia
29%
Blepharospasm
16%
Botulinum Neurotoxin (BoNT)
24%
Botulinum Toxin Injection
16%
Cervical Dystonia
10%
COL6A3
13%
Daily Clinical Practice
9%
Deep Brain Stimulation
15%
Disease Genes
9%
Dystonia
61%
Dystonic
14%
Early Onset
21%
Embouchure Dystonia
33%
Event-related fMRI
11%
Exome
11%
Exome Sequencing
11%
Facial Expression
13%
Functional Connectivity
19%
Functional Magnetic Resonance Imaging
33%
Functional Neuroanatomy
10%
Generalized Dystonia
13%
Haploinsufficiency
9%
Healthy Controls
11%
HIV Infection
11%
Imitation
9%
Isolated Dystonia
25%
KMT2B
11%
Long-term Efficacy
13%
Long-term Safety
13%
Meige Syndrome
13%
Motor Cortex
12%
Musicians
16%
OnabotulinumtoxinA
10%
Orofacial Dystonia
14%
Parkinson Patients
9%
Parkinson's Disease
38%
Patients with Parkinson's Disease
9%
Pianist
9%
Positron Emission Tomography Study
9%
Premotor
19%
Premotor Cortex
19%
Psychomotor Slowing
13%
Putamen
9%
Resting-state Functional Connectivity (rs-FC)
11%
Sensorimotor
14%
Somatosensory Activation
9%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
24%
Superior Parietal Cortex
9%
Whole Exome Sequencing
16%
Writer's Cramp
19%
Neuroscience
Amygdala
8%
Anterior Cingulate Cortex
6%
Association Cortex
5%
Auditory Cortex
5%
Basal Ganglia
30%
Blepharospasm
13%
Brain Activation
5%
Central Nervous System
5%
Cerebellum
12%
Clostridium Botulinum Type A
15%
Disgust
5%
Dystonia
100%
Electrical Brain Stimulation
22%
Exome Sequencing
16%
Face
12%
Fractional Anisotropy
5%
Functional Connectivity
19%
Functional Magnetic Resonance Imaging
50%
Gene Mutation
5%
Gray Matter
5%
HIV Associated Dementia
5%
Human Immunodeficiency Virus
25%
Inferior Frontal Gyrus
6%
L-DOPA
5%
Motor Cortex
7%
Neuroanatomy
10%
Neuropathy
5%
Parietal Cortex
13%
Parkinson's Disease
40%
Positron Emission Tomography
10%
Premotor Cortex
27%
Putamen
9%
Sensorimotor Integration
5%
Sensory Processing
5%
Spasmodic dysphonia
9%
Stereotypic Movement Disorder
13%
Subthalamic Nucleus
20%
Supplementary Motor Area
5%
Temporal Lobe
6%
Thalamus
11%
